Skip to main content
. Author manuscript; available in PMC: 2019 Jun 21.
Published in final edited form as: Leuk Lymphoma. 2012 Sep 8;54(1):167–173. doi: 10.3109/10428194.2012.708026

Figure 3. Induction of NK Ligand Expression on Primary ALL Blasts.

Figure 3

(A-C) Scatter plots showing effect of drug treatment on NKG2D ligand expression (ΔMFI above isotype control) for each of 3 primary ALL samples treated in duplicate with: A) 50nM Bortezomib, B) 1mM Valproate and C) 5μM Troglitazone compared with vehicle controls. Ligands MICA, MICB, ULBP1 and ULBP2 as indicated (*p<0.05, **p<0.01).